Steven Cohen’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Steven Cohen's URGN Position: Q3 2026 in Review
Steven Cohen sold out of UroGen Pharma (URGN) in Q3 2026, closing a stake of 1,525,549 shares — an estimated $56.1M sold.
Steven Cohen first reported a position in URGN in Q3 2018 and held it in 15 quarters. The position peaked at $56.1M in Q2 2026. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Steven Cohen reported no remaining UroGen Pharma position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 1,525,549 UroGen Pharma shares in Q3 2026, an estimated $56.1M.
- Steven Cohen first reported a position in UroGen Pharma in Q3 2018 and held it in 15 quarters.
- Steven Cohen's UroGen Pharma position peaked at $56.1M in Q2 2026.
- 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.